Technology
Morgan Stanley has elevated Quantinuum to its preferred investment within the pure-play quantum computing sector, upgrading the company to Overweight from Equal-weight. Analyst Joseph Moore cited its technical progress, execution record, and comparatively low valuation multiple relative to peers.
The bank lowered its price target to $62 from $78. Despite the reduction, the target implied approximately 88% upside from the recent trading level cited in the report. Quantinuum shares rose approximately 4.9% in premarket trading following the announcement, while IonQ shares declined 2.6%.
Morgan Stanley maintained its Equal-weight rating on IonQ and initiated coverage of Infleqtion and Xanadu with Equal-weight ratings. The differentiated recommendations reflect the firm’s assessment of competing technologies, development progress, manufacturing potential, and commercial execution.
Morgan Stanley evaluates quantum computing companies through a proprietary framework covering technical progress, execution, manufacturability, and indicators of commercial momentum. Technical achievement receives the greatest weight because conventional financial measures remain limited in an industry where current revenue is still negligible.
Within this framework, Quantinuum has reached Stage 7 of Morgan Stanley’s eight-stage error-correction scale, compared with Stage 4 for IonQ. The report also states that Quantinuum’s protected quantum operations are approximately 4.3 times more reliable than operations without error protection.
Quantinuum’s development of three generations of quantum computers using the same underlying technology further supports the analyst’s assessment of its execution capabilities.
IonQ retains a potential advantage in manufacturability through its Superion architecture, which shifts gate control toward on-chip electronics. However, Morgan Stanley noted that IonQ’s strongest error-correction results have not yet been reproduced on Superion, leaving an important technical question unresolved.
Morgan Stanley’s upgrade is also based on the difference between Quantinuum’s technical progress and its valuation relative to projected future revenue. The analyst considers the company to trade at the lowest revenue multiple among its peers when measured against 2030 projections.
The firm’s forecasts place Quantinuum’s computing revenue at $2 billion by 2030, compared with $1.8 billion for IonQ. Morgan Stanley assigns Quantinuum a 75% visibility factor, versus 70% for IonQ, reflecting its assessment of the companies’ respective prospects for achieving their long-term targets.
These figures are forecasts, not established financial results. Their eventual realization will depend on technological development, the ability to scale production, customer adoption, and the emergence of commercially viable applications.
The expected arrival of Quantinuum’s Sol system and IonQ’s Superion 256 around 2027 could provide important evidence of each company’s ability to execute its development roadmap. The planned Sol launch is identified as a potential catalyst for Quantinuum.
Morgan Stanley estimates that quantum computing could create a market exceeding $100 billion by 2040. However, the size of that potential market does not establish how quickly demand will develop or which companies will capture the greatest share of its economic value.
The report also cites TipRanks data showing Strong Buy consensus ratings for both Quantinuum and IonQ, with average price targets implying potential upside of 182.7% for Quantinuum and 124.2% for IonQ. These figures reflect analyst expectations and should not be interpreted as guaranteed returns.
For investors, the distinction between technological leadership and investment performance remains central. Quantinuum’s progress may strengthen its competitive position, but the investment case still depends on future milestones, funding requirements, commercialization timelines, and valuation assumptions.
For high-net-worth investors and internationally diversified families, exposure to emerging technologies warrants careful portfolio sizing and risk assessment. Quantum computing may offer long-term growth potential, but concentrated positions in pre-commercial businesses can introduce substantial volatility and uncertainty.
Morgan Stanley’s revised recommendation provides a framework for evaluating relative prospects rather than definitive evidence of future success. Investors should distinguish between demonstrated technical progress, projected financial performance, and market expectations already reflected in share prices.
Quantinuum’s promotion to Morgan Stanley’s top quantum computing pick highlights the growing importance of error correction, repeatable technical execution, and credible scaling plans in a sector still searching for broad commercial adoption.
The lower price target alongside the upgrade illustrates an important investment principle: a more favorable relative assessment does not eliminate valuation risk. The anticipated 2027 product milestones and longer-term revenue forecasts will be important tests of whether Quantinuum can translate its technical progress into sustainable commercial results.
For wealth managers and strategic investors, the opportunity requires balancing exposure to transformative technology with disciplined capital allocation, diversification, and realistic assessments of uncertainty.
For a confidential discussion regarding retail banking strategy, insurance distribution models, customer loyalty ecosystems, digital financial services, or cross-border financial innovation opportunities, contact our senior advisory team.
October 13, 2026
October 11, 2026
October 11, 2026
October 11, 2026